GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · Real-Time Price · USD
4.390
0.00 (0.00%)
At close: Oct 8, 2025, 4:00 PM EDT
4.370
-0.020 (-0.46%)
After-hours: Oct 8, 2025, 5:52 PM EDT
GoodRx Holdings Market Cap
GoodRx Holdings has a market cap or net worth of $1.53 billion as of October 8, 2025. Its market cap has decreased by -40.27% in one year.
Market Cap
1.53B
Enterprise Value
1.79B
1-Year Change
-40.27%
Ranking
Category
Stock Price
$4.39
Market Cap Chart
Since the IPO on September 23, 2020, GoodRx Holdings's market cap has decreased from $12.67B to $1.53B, a decrease of -87.96%. That is a compound annual growth rate of -34.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 1.53B | -14.75% |
| Dec 31, 2024 | 1.79B | -34.24% |
| Dec 29, 2023 | 2.72B | 47.38% |
| Dec 30, 2022 | 1.85B | -85.84% |
| Dec 31, 2021 | 13.04B | -17.43% |
| Dec 31, 2020 | 15.79B | 24.57% |
| Sep 23, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.44B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |